Programme
08:30
Registration
09:00
Opening/welcome
René Leemans/Andreas Dietz/Wojciech Golusinski
Epidemiology and carcinogenesis
Chairs: Andreas Dietz/Wojciech Golusinski
09:30
Epidemiology of oral/oropharyngeal HPV infection
Maura Gillisson (to be confirmed)
09:50
HPV-mediated carcinogenesis
Ruud Brakenhoff
10:10
World wide incidence of HPV in OPSCC
Pawel Golusinski
10:30
EMT and stem cells in HPV HNSCC
Jochen Hess
10:50
Coffee
11:20
Free papers
Prognostic impact HPV in OPSCC
Chairs: Ruud Brakenhoff/ Maura Gillison
12:00
Validation of statistical models for OPSCC
Robert Baatenburg de Jong
12:20
HPV risk modeling 2.0
Gunnar Wichman
12:40
Subclassification of HPV-OPSCC by gene expression
Lisa Licitra
13:00
Lunch (symposium)
Treatment of HPV+ve OPSCC
Chairs: René Leemans/Bob Ferris
14:00
Treatment of HPV disease by transoral robotic surgery
Christian Simon
14:20
Treatment of HPV disease by laser surgery
Terry Jones
14:40
Treatment of HPV disease with (chemo)radiotherapy
Vincent Gregoire
15:00
Free papers
15:30
Coffee
Session title to be announced
Chairs: Christian Simon/Stephan Lang
16:00
Are there alternatives for 3 weekly cisplatin in HPV disease
Jan Vermorken
16:20
Salvage surgery for HPV disease
Carole Fakhry
16:40
Debate: This house believes that TNM8 was implemented too early for HPV+ve OPSCC
For: Hisham Mehanna/Against: Brian O’Sullivan (to be confirmed)
17:00
Posters and Drinks
19:00
Social evening
Therapy developments in HPV+ve OPSCC
Chairs: Jan Vermorken/Vincent Gregoire
09:00
Free papers
09:30
De-escalation of non-surgical therapy
Hisham Mehanna
09:50
De-escalation using surgery
Bob Ferris (to be confirmed)
10:10
Is proton therapy preferable for HPV+ve OPSCC?
Hans Langendijk
10:30
Coffee
Session title to be announced
Chairs: Lisa Licitra/Hans Langendijk
11:00
Free papers
11:20
Next generation robotics
Stephan Lang
11:40
Immunotherapy for HPV driven disease
Maura Gillison (to be confirmed)
12:00
Tumor board (moderator: Terry Jones)
Wojciech Golusinski, Stephan Lang, Hans Langendijk, Lisa Licitra, Bob Ferris
13:00
Lunch (symposium)
Future perspectives in HPV research
Chairs: Rieneke van de Ven/Ingeborg Tinhofer-Keilholz
14:00
Therapeutic HPV vaccination
Sjoerd van der Burg
14:20
HPV in non-oropharygeal HNSCC: does it play a role?
René Leemans
14:40
Free papers
Screening and Prevention
Chair: Andreas Dietz
15:10
Round Table screening and prevention
Discussion leader: Andreas Dietz
5-slide Pitch Hans Berkhof: Preventive vaccination, also in treated OPSCC patients?
5-slide Pitch Tim Waterboer: HPV serology for screening
5-slide Pitch Ingeborg Tinhofer-Keilholz: HPV DNA assays for screening
5-slide Pitch Carole Fakhry: Positively screened for HPV: which intervention?
16:00
Round table discussion: screening and prevention
16:30
Closing remarks
Wojciech Golunski
16:40
Adjourn